Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia

Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia

Dec 07, 2013
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia-0